PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsblood protein disorders
MeSH D001796 - blood protein disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006402:Hematologic diseases
33 Companies
3 Drugs
$
Success rate
D001796: 
Blood protein disorders
1 Company
1 Drug
$
Success rate
D000361:Agammaglobulinemia
0 Companies
0 Drugs
Success rate
D004406:Dysgammaglobulinemia
0 Companies
0 Drugs
Success rate
D006942:Hypergammaglobulinemia
0 Companies
0 Drugs
Success rate
D007019:Hypoproteinemia
0 Companies
0 Drugs
Success rate
D010265:Paraproteinemias
1 Company
1 Drug
$
Success rate
D018455:Protein s deficiency
0 Companies
0 Drugs
Success rate
D020151:Protein c deficiency
1 Company
0 Drugs
Success rate
D020152:Antithrombin iii deficiency
1 Company
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%
6/6
Phase 2
6%
1/18
Phase 3
50%
1/2
Approved: 1Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bristol Myers Squibb
Idecabtagene vicleucel
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use